Product Images Raloxifene Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Raloxifene Hydrochloride NDC 0093-7290 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image 1
HCI stands for Human-Computer Interaction. It is an interdisciplinary field that focuses on the design and evaluation of computer systems from the perspective of the user. The goal of HCI is to make computer systems more intuitive, user-friendly, and accessible to a wider range of people. It draws on a range of disciplines, including computer science, psychology, and design, to create technologies that people can use with ease and effectiveness.*
image 2
Total hip mean percentage change from baseline for subjects in studies A and EU who received either placebo or raloxifene hydrochloride for 24 months, as well as for subjects who received either placebo, raloxifene hydrochloride, or conjugated estrogens for 24 months in study INT (hysterectomized women). The chart displays the changes at different months after randomization.*
image 3
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.